Author |
Title |
Year |
Publication |
Volume |
Pages |
Oliva, C.R.; Zhang, W.; Langford, C.; Suto, M.J.; Griguer, C.E. |
Repositioning chlorpromazine for treating chemoresistant glioma through the inhibition of cytochrome c oxidase bearing the COX4-1 regulatory subunit |
2017 |
Oncotarget |
8 |
37568-37583 |
Kim, M.Y.; Park, S.-J.; Shim, J.W.; Song, Y.J.; Yang, K.; Park, S.-J.; Heo, K. |
Accumulation of low-dose BIX01294 promotes metastatic potential of U251 glioblastoma cells |
2017 |
Oncology Letters |
13 |
1767-1774 |
Shahar, T.; Rozovski, U.; Hess, K.R.; Hossain, A.; Gumin, J.; Gao, F.; Fuller, G.N.; Goodman, L.; Sulman, E.P.; Lang, F.F. |
Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival |
2017 |
Neuro-Oncology |
19 |
660-668 |
Roy, A.; Attarha, S.; Weishaupt, H.; Edqvist, P.-H.; Swartling, F.J.; Bergqvist, M.; Siebzehnrubl, F.A.; Smits, A.; Ponten, F.; Tchougounova, E. |
Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression |
2017 |
Oncotarget |
8 |
24815-24827 |
Emery, I.F.; Gopalan, A.; Wood, S.; Chow, K.-H.; Battelli, C.; George, J.; Blaszyk, H.; Florman, J.; Yun, K. |
Expression and function of ABCG2 and XIAP in glioblastomas |
2017 |
Journal of Neuro-Oncology |
133 |
47-57 |